(Q44763754)

6 December 2017

title

Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients (English)

1 reference

6 December 2017

Thomas Raife

1

1 reference

6 December 2017

Bonnie Atkinson

2

1 reference

6 December 2017

Robert Montgomery

3

1 reference

6 December 2017

Sara Vesely

4

1 reference

6 December 2017

Kenneth Friedman

5

1 reference

6 December 2017

publication date

1 February 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

44

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

146-150

1 reference

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Moschcowitz, multimers, and metalloprotease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: will recent insight into pathogenesis translate into better treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.00626.X

10.1111/J.1537-2995.2004.00626.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference